Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Clin Immunol. 2015 Jul 6;160(2):319–327. doi: 10.1016/j.clim.2015.07.001

Fig. 1.

Fig. 1

LD is associated with increased disease activity in SLE. A) Assessment of disease activity by SLEDAI in 90 patients with LD defined as ≥2-fold elevation of AST or ALT, 126 patients with iLD defined as <2-fold elevation of AST or ALT, and 219 patients with normal LFTs. B) Modified SLEDAI scores in patients with LD, iLD, and normal LFTs after excluding anti-DNA and complement values. Data represent mean ± SEM. p values indicate comparison with two-tailed unpaired t-test.